In Vitro Diagnostics: Technologies and Global Markets
In Vitro Diagnostics: Technologies and Global Markets
Abstract
In Vitro Diagnostics Market- Report Scope:
The scope of this study is global. BCC Research analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, Korea, Taiwan, Africa, Australia, Brazil and Russia, among others. The report also examines IVD market drivers, as well as restraints and challenges affecting its growth.
Further, the IVD market report also highlights the emerging products and technologies and associated start-ups that are likely to accelerate the growth of the IVD industry through their best practices in the research and development of IVDs. Excluded from this study is diagnostic testing such as imaging, veterinary diagnostics and their associated products.
This study will provide information on these areas -
- Structure and current market size of the IVD market as outlined with forecasts through 2025.
- Impact of chronic diseases, growing and aging populations.
- Current technology and product suppliers and key innovations.
- A look at the IVD industry and trends affecting the market.
- Markets by each segment (immunochemistry, molecular diagnostics, POC tests, clinical microbiology, hematology and tissue diagnostics).
- A global overview showing market data for North America, Europe, Asia-Pacific and Latin America, Africa and the Middle East (LAAM).
- Emerging opportunities and potential investment opportunity areas for IVD.
- Technology patent trends relating to IVD.
- Profiles for more than 20 companies in the industry with significant contributions and market shares.
In Vitro Diagnostics- Report Includes:
- 47 data tables and 21 additional tables
- An overview of the global market for in vitro diagnostics (IVD) within the industry
- Analyses of global market trends, with data from 2019-2020, and projections of compound annual growth rates (CAGRs) through 2025
- Assessment of market dynamics such as drivers, restraints, opportunities, and identification of growth inhibiting areas that affect the global market
- Evaluation of market size and forecast, and technological advancements within the industry; and market share analysis of the global IVD market by application, segment and region
- A look at how the rise in the number of diseases like respiratory infections, hospital acquired infections (HAI), and sexually transmitted diseases are creating a constant need for IVD testing in hospitals and laboratories
- Coverage of technologies such as IVD for neglected infectious diseases, chemistry-based portable analysis and discussion on advantages of microfluidic platform based POC tests
- Detailed description on COVID-9 pandemic, including symptoms, and progression; information on coronavirus disease 2019 testing basics and impact analysis of COVID-19 on the IVD market
- Comprehensive company profiles of major market players, including Abbott Diagnostics Inc., Beckman Coulter, Becton, Dickinson and Co., Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthcare and Thermo Fisher Scientific Inc.
Content
Table of Contents Chapter 1 Introduction Study Goals and Objectives Reasons for Doing This Study Intended Readership Scope of Report Methodology Geographic Breakdown Analyst's Credentials BCC Custom Research Related BCC Research Reports Chapter 2 Summary and Highlights Global Market Trends Chapter 3 Market Landscape COVID-19 Global Pandemic Coronavirus Disease 2019 Testing Basics Diagnostic Tests with Alternative Options Molecular Diagnostic Tests Increasing Access to Testing Antigen Tests Antibody (Serology) Tests In Vitro Diagnostic Testing EUAs Diagnostic Tests Serology/Antibody Tests Tests for the Management of COVID-19 Patients Market Overview and Segmentation Key Findings Factors Influencing the Global IVD Market Drivers Challenges Regulatory Landscape IVD Regulations in North America IVD Regulations in Europe IVD Regulations in Asia-Pacific IVD Regulations in LAAM (Latin America, Africa and Middle East) Chapter 4 Global Market for IVD by Product Segment Immunochemistry POC IVD Molecular Diagnostic Testing Hematology Clinical Microbiology Tissue Diagnostic Testing Trends in IVD Segments Competitive Structure Market Share Analysis Chapter 5 Global Market for Immunochemistry Testing Blood Gas, Electrolytes and Metabolites (BGEM) Endocrine Infectious Diseases Cancer Urinalysis Diabetes Cardiology Blood Screening Others FDA Product Approvals in 2020 Chapter 6 Global Market for POC Testing Glucose Testing BGEM Cardiac Marker Testing Infectious Disease Testing Pregnancy and Fertility Testing Drug and Alcohol Abuse Testing Hematology and Hemostasis Testing Cholesterol Testing Urine Chemistry Testing Tumor Marker Testing Other Types of POC Testing FDA Product Approvals in 2020 Chapter 7 Global Market for Hematology Testing Routine Hematology Tests Hemostasis FDA Product Approvals in 2020 Chapter 8 Global Market for Molecular Diagnostic Testing Infectious Diseases Blood Screening Oncology Genetic Testing Others (Companion Diagnostics, Prenatal Genetic Tests and Rare Diseases) FDA Product Approvals in 2020 Chapter 9 Global Market for Clinical Microbiology Testing Blood Culture General Culture (Urine/Saliva/Stool/Sputum/CSF and Other Body Fluids) Identification and Antibiotic Susceptibility Testing FDA Product Approvals in 2020 Chapter 10 Global Market for Tissue Diagnostic Testing Cancer Diagnosis Tissue Typing Pathogen Detection Chapter 11 Regional Analysis Introduction North America Europe Asia-Pacific LAAM International Health Expenditure and Trends North America Europe Western Europe Central and Eastern Europe Asia-Pacific Latin America, Africa and Middle East (LAAM) Chapter 12 Market Trends End Users Trends Product Categories Trends Technology Trends Industry Developments Opportunities IVD for Neglected Infectious Diseases Portable Devices Compatible with Simple Detection Platforms Chemistry-Based Portable Analyzers Improved Sample Preservation Technologies New Detection Technologies Alternative Technologies to PCR Key Biomarkers for Diseases of the Developing World Microfluidic Platform-based POC Tests for Remote Settings Combining Multiple Detection Technologies into a Single Instrument Chapter 13 Mergers and Acquisitions Chapter 14 Patent Review Coronavirus COVID-19 Diagnostics Chapter 15 Company Profiles ABBOTT DIAGNOSTICS INC. ALERE SAN DIEGO INC. ASCENSIA DIABETES CARE BECKMAN COULTER (PART OF DANAHER) BECTON DICKINSON AND CO. BIOMERIEUX BIO-RAD DANAHER CORP. ELITECH GROUP HOLOGIC INC. INSTRUMENTATION LABORATORY KEMENTEC A/S ORTHO CLINICAL DIAGNOSTICS ROCHE DIAGNOSTICS CORP. QUIDEL CORP. SIEMENS HEALTHCARE DIAGNOSTICS INC. SYSMEX THERMO FISHER SCIENTIFIC INC. TRANSASIA BIO-MEDICALS WERFEN GROUP Chapter 16 Appendix List of IVD Market Participants List of Acronyms
In Vitro Diagnostics Market- Report Scope:
The scope of this study is global. BCC Research analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, Korea, Taiwan, Africa, Australia, Brazil and Russia, among others. The report also examines IVD market drivers, as well as restraints and challenges affecting its growth.
Further, the IVD market report also highlights the emerging products and technologies and associated start-ups that are likely to accelerate the growth of the IVD industry through their best practices in the research and development of IVDs. Excluded from this study is diagnostic testing such as imaging, veterinary diagnostics and their associated products.
This study will provide information on these areas -
- Structure and current market size of the IVD market as outlined with forecasts through 2025.
- Impact of chronic diseases, growing and aging populations.
- Current technology and product suppliers and key innovations.
- A look at the IVD industry and trends affecting the market.
- Markets by each segment (immunochemistry, molecular diagnostics, POC tests, clinical microbiology, hematology and tissue diagnostics).
- A global overview showing market data for North America, Europe, Asia-Pacific and Latin America, Africa and the Middle East (LAAM).
- Emerging opportunities and potential investment opportunity areas for IVD.
- Technology patent trends relating to IVD.
- Profiles for more than 20 companies in the industry with significant contributions and market shares.
In Vitro Diagnostics- Report Includes:
- 47 data tables and 21 additional tables
- An overview of the global market for in vitro diagnostics (IVD) within the industry
- Analyses of global market trends, with data from 2019-2020, and projections of compound annual growth rates (CAGRs) through 2025
- Assessment of market dynamics such as drivers, restraints, opportunities, and identification of growth inhibiting areas that affect the global market
- Evaluation of market size and forecast, and technological advancements within the industry; and market share analysis of the global IVD market by application, segment and region
- A look at how the rise in the number of diseases like respiratory infections, hospital acquired infections (HAI), and sexually transmitted diseases are creating a constant need for IVD testing in hospitals and laboratories
- Coverage of technologies such as IVD for neglected infectious diseases, chemistry-based portable analysis and discussion on advantages of microfluidic platform based POC tests
- Detailed description on COVID-9 pandemic, including symptoms, and progression; information on coronavirus disease 2019 testing basics and impact analysis of COVID-19 on the IVD market
- Comprehensive company profiles of major market players, including Abbott Diagnostics Inc., Beckman Coulter, Becton, Dickinson and Co., Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthcare and Thermo Fisher Scientific Inc.
Table of Contents Chapter 1 Introduction Study Goals and Objectives Reasons for Doing This Study Intended Readership Scope of Report Methodology Geographic Breakdown Analyst's Credentials BCC Custom Research Related BCC Research Reports Chapter 2 Summary and Highlights Global Market Trends Chapter 3 Market Landscape COVID-19 Global Pandemic Coronavirus Disease 2019 Testing Basics Diagnostic Tests with Alternative Options Molecular Diagnostic Tests Increasing Access to Testing Antigen Tests Antibody (Serology) Tests In Vitro Diagnostic Testing EUAs Diagnostic Tests Serology/Antibody Tests Tests for the Management of COVID-19 Patients Market Overview and Segmentation Key Findings Factors Influencing the Global IVD Market Drivers Challenges Regulatory Landscape IVD Regulations in North America IVD Regulations in Europe IVD Regulations in Asia-Pacific IVD Regulations in LAAM (Latin America, Africa and Middle East) Chapter 4 Global Market for IVD by Product Segment Immunochemistry POC IVD Molecular Diagnostic Testing Hematology Clinical Microbiology Tissue Diagnostic Testing Trends in IVD Segments Competitive Structure Market Share Analysis Chapter 5 Global Market for Immunochemistry Testing Blood Gas, Electrolytes and Metabolites (BGEM) Endocrine Infectious Diseases Cancer Urinalysis Diabetes Cardiology Blood Screening Others FDA Product Approvals in 2020 Chapter 6 Global Market for POC Testing Glucose Testing BGEM Cardiac Marker Testing Infectious Disease Testing Pregnancy and Fertility Testing Drug and Alcohol Abuse Testing Hematology and Hemostasis Testing Cholesterol Testing Urine Chemistry Testing Tumor Marker Testing Other Types of POC Testing FDA Product Approvals in 2020 Chapter 7 Global Market for Hematology Testing Routine Hematology Tests Hemostasis FDA Product Approvals in 2020 Chapter 8 Global Market for Molecular Diagnostic Testing Infectious Diseases Blood Screening Oncology Genetic Testing Others (Companion Diagnostics, Prenatal Genetic Tests and Rare Diseases) FDA Product Approvals in 2020 Chapter 9 Global Market for Clinical Microbiology Testing Blood Culture General Culture (Urine/Saliva/Stool/Sputum/CSF and Other Body Fluids) Identification and Antibiotic Susceptibility Testing FDA Product Approvals in 2020 Chapter 10 Global Market for Tissue Diagnostic Testing Cancer Diagnosis Tissue Typing Pathogen Detection Chapter 11 Regional Analysis Introduction North America Europe Asia-Pacific LAAM International Health Expenditure and Trends North America Europe Western Europe Central and Eastern Europe Asia-Pacific Latin America, Africa and Middle East (LAAM) Chapter 12 Market Trends End Users Trends Product Categories Trends Technology Trends Industry Developments Opportunities IVD for Neglected Infectious Diseases Portable Devices Compatible with Simple Detection Platforms Chemistry-Based Portable Analyzers Improved Sample Preservation Technologies New Detection Technologies Alternative Technologies to PCR Key Biomarkers for Diseases of the Developing World Microfluidic Platform-based POC Tests for Remote Settings Combining Multiple Detection Technologies into a Single Instrument Chapter 13 Mergers and Acquisitions Chapter 14 Patent Review Coronavirus COVID-19 Diagnostics Chapter 15 Company Profiles ABBOTT DIAGNOSTICS INC. ALERE SAN DIEGO INC. ASCENSIA DIABETES CARE BECKMAN COULTER (PART OF DANAHER) BECTON DICKINSON AND CO. BIOMERIEUX BIO-RAD DANAHER CORP. ELITECH GROUP HOLOGIC INC. INSTRUMENTATION LABORATORY KEMENTEC A/S ORTHO CLINICAL DIAGNOSTICS ROCHE DIAGNOSTICS CORP. QUIDEL CORP. SIEMENS HEALTHCARE DIAGNOSTICS INC. SYSMEX THERMO FISHER SCIENTIFIC INC. TRANSASIA BIO-MEDICALS WERFEN GROUP Chapter 16 Appendix List of IVD Market Participants List of Acronyms
Related Report
